Pavmed Inc (PAVM) Stock Price, Quote & News

Company Profile

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precance...

Industry: Medical Devices

Sector: Healthcare

Phone: 917 813 1828

Website: www.pavmed.com

Address:

360 Madison Avenue, 25th Floor, New York, United States

chuckjackson Sep. 18 at 12:05 AM

$PAVM the biggest crime would be if lucd gets the draft and pavm just crosses $6.50. We get jack and Lishan gets $30M

0 · Reply

traderjoe2018 Sep. 16 at 4:12 PM

$PAVM up 3% sweet. I may need about 1000x that to recoup what I have lost. lol

0 · Reply

chuckjackson Sep. 15 at 12:52 AM

$PAVM @BigJuicy I've seen you post that you would settle for $14. Do you really believe that the stock will spike anywhere close to that? When it spiked earlier in the year, there were only 800k shares. Now there are 8M shares which will become 12.61M if all goes as planned for Lishan. For pavm to reach $14 based on the valuation of lucd, lucd will need to hit $5.21 which would be a 659% appreciation for lucd. At this point, I think it's a salvage mission. We will be lucky to get $8-10. That is my guess

0 · Reply

chuckjackson Sep. 15 at 12:30 AM

$PAVM $LUCD there is no way pavm has better prospects than lucd. Assumptions: total number of shares outstanding for pavm 12.71M assuming warrants are called, 31M shares of lucd, $15M debt, pet projects not assigned a value given they will only drain cash for the foreseeable future. Total number of shares outstanding for lucd is 235M

1 · Reply

chuckjackson Sep. 15 at 12:06 AM

$PAVM $LUCD @oaksapollo When pavm spiked up on the VA news, there were about 800k shares. There are now 8M shares. In addition, if lucd receives the draft and pavm stock is above $6.50, they will issue another 4.61M additional shares priced at $6.50

0 · Reply

oaksapollo Sep. 14 at 6:57 PM

$PAVM trading up on higher than average volume. Maybe just me, but if someone tipped me off that good news was coming on the LCD, I would go buy PAVM, not $LUCD, so maybe it's a good sign. On the VA news, PAVM went to $28 because the float is so low. It's significantly better than directly owning LUCD if you're just looking to short-term trade the news.

1 · Reply

chuckjackson Sep. 14 at 5:37 AM

$PAVM $LUCD @oaksapollo looks like they were ok with using the atm with pavm when the stock priced was at its lower levels. So the new atm for pavm doesn't necessarily mean good news is coming. They will dump the shares at the lower price since they are desperate

0 · Reply

chuckjackson Sep. 11 at 10:39 PM

$PAVM when I last checked on July 30, there were 7.27M shares. There are now 7.99M shares. Where did all these shares come from? That's 10% dillution

4 · Reply

BigJuicy Sep. 11 at 12:55 PM

$PAVM another day. My call is LCD draft 9/17 or 9/24. I’m not even thinking October. Positive thoughts. $LUCD

1 · Reply

InvestinRedemption Sep. 10 at 11:51 PM

$PAVM Yeah obviously I got taken to the woodshed to the tune of 7-figures on this company (sounds ridiculous to even fathom). But despite that horrendous decision, one of the best I made was to GET OUT a couple years ago. Hey… maybe someday I look bad again when it skyrockets on Varis going viral, you never know. That’s part of why I’m still checking up here. But the peace of mind of being rid of this absolute disgusting excuse of management has been nice, while also the broader market where I now have everything placed has done well…so I will be just fine. As much of a deranged, obsessive ahole as LPlates is… he’s absolutely been right about how disgusting those people are and how mismanaged this company is. Lesson learned the hard way for me, best of luck to you all but strongly suggest doing the same if you have significant capital tied here $LUCD

5 · Reply

PAVmed price target raised to $57 from $56 at Ascendiant

2026-08-16T13:31:29.000Z - 4 weeks ago

PAVmed reports Q2 adjusted EPS (27c) vs. ($1.40) last year

Aug 14, 2026, 8:30 AM EDT - 5 weeks ago

PAVmed Earnings Call Transcript: Q2 2026

Aug 14, 2026, 8:30 AM EDT - 5 weeks ago

PAVmed Quarterly report: Q2 2026

Aug 14, 2026, 8:30 AM EDT - 5 weeks ago

PAVmed Slides: Q2 2026

Aug 14, 2026, 8:30 AM EDT - 5 weeks ago

PAVmed Earnings release: Q2 2026

Aug 14, 2026, 8:00 AM EDT - 5 weeks ago

Market Cap	31.34M
Revenue (ttm)	70,000.00
Net Income (ttm)	400,000.00
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	571.43%
Debt to Equity Ratio	0.78

Volume	7,193
Avg Vol	31,072
Day's Range	N/A - N/A
Shares Out	8.00M
Stochastic %K	16%
Beta	0.53
Analysts	Sell
Price Target	$36.50